Brief: Compugen Further Expands Patent Portfolio For Tigit Inhibitor Com902 With Composition Of Matter Patent In China
02/11/2020 12:34
Nov 2 (Reuters) - Compugen Ltd CGEN.TA :
* COMPUGEN FURTHER EXPANDS PATENT PORTFOLIO FOR TIGIT
INHIBITOR
COM902 WITH COMPOSITION OF MATTER PATENT IN CHINA
* COMPUGEN LTD - NEW PATENT EXPANDS COMPOSITION OF MATTER
AND USE
PROTECTION FOR COM902 BEYOND UNITED STATES AND EUROPE
Source text for Eikon: ID:nPn4SLyNWa
Further company coverage: CGEN.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Compugen
See all newsIsrael's Compugen Q2 revenue more than doubles, net loss narrows
Brief: Compugen Announces The Appointment Of Michele Holcomb, Ph.D., To Its Board Of Directors
Brief: Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million
Brief: Compugen Announces First Patient Dosed In Com701 Global Platform Trial In Platinum Sensitive Ovarian Cancer
Brief: Compugen Announces Leadership Transitions Effective September 2025